Clinical Trial Update: Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial [Phase 3]

View source ↗

Summary

An ongoing randomized Phase III trial (EXPAND) is evaluating outcomes for pancreatic cancer patients with nominal oligometastatic disease; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pancreas Cancer, Oligometastatic | Phase 3 | Status: RECRUITING